---
schema_version: "secwatch.filing_event.v1"
accession: "0001628280-22-025942"
form_type: "8-K"
ticker: "ABSI"
cik: "0001672688"
company_name: "Absci Corp"
filed_at: "2022-10-04T23:59:59+00:00"
generated_at: "2026-06-23T05:36:35.295820+00:00"
event_type: "leadership"
sentiment: "positive"
materiality_score: 0.6
calibrated_materiality_score: 0.6
confidence: "high"
source: SEC EDGAR
---

# Absci appoints Andreas Busch as Chief Innovation Officer; CTO Matthew Weinstock transitions to consultant

## Summary
- Andreas Busch resigns from Board on Sept 30 to become Chief Innovation Officer effective Oct 4, 2022.
- Former CTO Matthew Weinstock to serve as consultant after Oct 4; receives 12-month base salary severance, COBRA reimbursement, and $145,125 prorated bonus.
- Dr. Busch brings R&D expertise from Sanofi, Bayer, Shire; led over 10 drugs to FDA approval.
- As Chief Innovation Officer, Dr. Busch will lead R&D, technical operations, and internal/partner programs.

## SEC filing metadata
- accession: 0001628280-22-025942
- form_type: 8-K
- ticker: ABSI
- cik: 0001672688
- company_name: Absci Corp
- filed_at: 2022-10-04T23:59:59+00:00
- event_type: leadership
- sentiment: positive
- materiality_score: 0.6
- calibrated_materiality_score: 0.6
- confidence: high
- sec_items: 5.02, 8.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1672688/000162828022025942/0001628280-22-025942-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1672688/000162828022025942/absc-20220930.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001628280-22-025942
- JSON: https://secwatch.observer/filing/0001628280-22-025942.json
- Plain text: https://secwatch.observer/filing/0001628280-22-025942.txt

## Key facts
- Executive change
  Andreas Busch was appointed as Chief Innovation Officer at Absci Corp.
  - Action: appointed
  - Role: Chief Innovation Officer
  source text: effective immediately upon his appointment as the Company's Chief Innovation Officer
  evidence_url: https://www.sec.gov/Archives/edgar/data/1672688/000162828022025942/0001628280-22-025942-index.htm
- Executive change
  Andreas Busch resigned as Director at Absci Corp.
  - Action: resigned
  - Role: Director
  source text: he would resign from the Company's Board of Directors
  evidence_url: https://www.sec.gov/Archives/edgar/data/1672688/000162828022025942/0001628280-22-025942-index.htm
- Executive change
  Matthew Weinstock changed role as Chief Technology Officer at Absci Corp.
  - Action: transitioned to consultant
  - Role: Chief Technology Officer
  source text: Matthew Weinstock, Ph.D., the Company's Chief Technology Officer, will transition into a consultant role on October 4, 2022.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1672688/000162828022025942/0001628280-22-025942-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.